Matthias Friebe

Company: Ratio Therapeutics

Job title: Chief Technology Officer

Seminars:

MACROPA™ – The Ring for Life or Keeping the Ac-225 Pay-Load on Your Targeting Vector 2:00 pm

MACROPA™ offers the possibility to label at room temperature and tolerates other metals being present during and post labeling MACROPA™ forms stable complexes holding the radioactive payload(s) for several days on the targeting vector MACROPA™ re-complexes formed (decay) Bi-213 (the only relevant daughter isotope) in the drug product vial over the shelf-life of the DP,…Read more

day: Conference Day 2